Insight Molecular Diagnostics, Inc. (IMDX)
6.63
+0.26
(+4.08%)
USD |
NASDAQ |
Dec 29, 16:00
6.50
-0.13
(-1.96%)
Pre-Market: 20:00
Insight Molecular Diagnostics EPS Diluted (Quarterly): -0.3388 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -1.646 |
| Veracyte, Inc. | 0.2401 |
| Exagen, Inc. | -0.3089 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.85M |
| Revenue (Quarterly) | 0.26M |
| Total Expenses (Quarterly) | 11.11M |
| Enterprise Value | 173.75M |
| Gross Profit Margin (Quarterly) | -162.7% |
| Profit Margin (Quarterly) | -4.17K% |
| Earnings Yield | -42.69% |
| Normalized Earnings Yield | -23.16 |